Seroatlas · Human Serome Atlas

GCSH

Glycine cleavage system H protein, mitochondrial

Also known as: GCSH_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P23434
Gene
GCSH
Ensembl
ENSG00000140905
Chromosome
16
Canonical length
173 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Vesicles

OverviewNCBI Gene

Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the H protein, which transfers the methylamine group of glycine from the P protein to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH). Two transcript variants, one protein-coding and the other probably not protein-coding,have been found for this gene. Also, several transcribed and non-transcribed pseudogenes of this gene exist throughout the genome.[provided by RefSeq, Jan 2010]

Canonical amino-acid sequenceUniProt

173 residues, UniProt reviewed canonical sequence.

>P23434|GCSH
     1  MALRVVRSVR ALLCTLRAVP SPAAPCPPRP WQLGVGAVRT LRTGPALLSV RKFTEKHEWV
    61  TTENGIGTVG ISNFAQEALG DVVYCSLPEV GTKLNKQDEF GALESVKAAS ELYSPLSGEV
   121  TEINEALAEN PGLVNKSCYE DGWLIKMTLS NPSELDELMS EEAYEKYIKS IEE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GCSH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.42
Highest tissue expression
134 nTPM

Expression across tissuesHPA

Tissue

  • midbrain: 134 nTPM
  • spinal cord: 121 nTPM
  • amygdala: 111 nTPM
  • liver: 111 nTPM
  • basal ganglia: 101 nTPM
  • thyroid gland: 90 nTPM

Single-cell type

  • epididymal principal cells: 17 nCPM
  • epididymal efferent duct absorptive cells: 12 nCPM
  • gastric chief cells: 8.7 nCPM
  • epididymal basal cells: 6.3 nCPM
  • extravillous trophoblasts: 5.9 nCPM
  • parietal cells: 5.3 nCPM

Immune cell

  • plasmacytoid DC: 11 nTPM
  • NK-cell: 7 nTPM
  • naive CD8 T-cell: 6 nTPM
  • MAIT T-cell: 4.6 nTPM
  • naive CD4 T-cell: 4.4 nTPM
  • memory CD8 T-cell: 4 nTPM

Brain region

  • white matter: 60 nTPM
  • basal ganglia: 58 nTPM
  • midbrain: 58 nTPM
  • thalamus: 55 nTPM
  • cerebellum: 52 nTPM
  • spinal cord: 50 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GCSH.

Disease | AllUniProt

Conditions GCSH is implicated in, by any mechanism.

Disease | GeneticClinVar

11 pathogenic / likely-pathogenic of 150 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.42
gnomAD pLI
0
gnomAD missense Z
0.09
DepMap mean gene effect
-0.34
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GCSH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GCSH as an antibody target. Whether an autoantibody or antibody against GCSH could matter depends on whether native GCSH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GCSH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GCSH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GCSH. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...